· Investment Strategies · 1 source
Garner Health's $100M Series E at $2.74B: Data-Driven Provider Selection
Garner Health raised $100M Series E led by Index Ventures in May 2026 at a $2.74B valuation, scaling its data platform for finding high-quality healthcare providers.
Editorial team
Garner Health's $100M Series E at a $2.74B valuation, led by Index Ventures in May 2026, backs a durable healthtech thesis: use data to point patients to the right providers.
The problem this startup is attacking
Healthcare quality varies enormously and is opaque to patients. Garner analyzes claims data to identify high-performing providers, helping employers cut costs and members get better outcomes.
Why this is a live problem now
- Employers face relentless healthcare cost inflation.
- Data-driven provider selection delivers measurable savings.
- AI can sharpen quality signals across massive claims datasets.
Competitive map
- Navigation and care-guidance platforms.
- Employer benefits and TPA incumbents.
- Payer-led steerage programs.
Market signal (the number to remember)
- $2.74B valuation at Series E — Index Ventures' lead signals confidence in healthcare data infrastructure as a defensible, cost-saving layer.
Practical takeaway (operator + investor)
Garner shows measurable cost outcomes still win in healthtech. Founders should lead with savings and quality evidence; investors should favor data-network businesses with employer demand and proof of ROI.
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.
